{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T07:08:08Z","timestamp":1763017688968,"version":"3.44.0"},"reference-count":8,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Reports"],"accepted":{"date-parts":[[2016,10,14]]},"abstract":"<jats:p>A woman aged 20\u2005years presented with fever and no localising signs. She was treated with cotrimoxazole and the subsequent blood culture was positive for <jats:italic>Salmonella typhi<\/jats:italic> (<jats:italic>S. typhi<\/jats:italic>), which was resistant to fluoroquinolones but susceptible to cotrimoxazole. Genotyping identified an FQ-R subclade of H58 <jats:italic>S. typhi<\/jats:italic>. Fever clearance time was 4 days after starting the antibiotics, and no relapses were noted on 2\u2005months of follow-up. This inexpensive, well-known and easily available antimicrobial could be suitably redeployed for fluoroquinolone-resistant enteric fever in South Asia.<\/jats:p>","DOI":"10.1136\/bcr-2016-217223","type":"journal-article","created":{"date-parts":[[2016,10,26]],"date-time":"2016-10-26T11:28:47Z","timestamp":1477481327000},"page":"bcr2016217223","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Cotrimoxazole treats fluoroquinolone-resistant <i>Salmonella typhi<\/i> H58 infection"],"prefix":"10.1136","volume":"2016","author":[{"given":"Manan","family":"Karki","sequence":"first","affiliation":[{"name":"Oxford University Clinical Research Unit, Patan Hospital, Kathmandu, Nepal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarbagya","family":"Pandit","sequence":"additional","affiliation":[{"name":"Oxford University Clinical Research Unit, Patan Hospital, Kathmandu, Nepal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Baker","sequence":"additional","affiliation":[{"name":"Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Buddha","family":"Basnyat","sequence":"additional","affiliation":[{"name":"Oxford University Clinical Research Unit, Patan Hospital, Kathmandu, Nepal"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2016,10,26]]},"reference":[{"key":"2025082701081465000_2016.oct26_1.bcr2016217223.1","doi-asserted-by":"crossref","unstructured":"Parry C , Basnyat B . Typhoid and paratyphoid fevers. In: Warrell D , Cox TM , Firth JD , eds. Oxford textbook of medicine. 5th edn. Oxford, UK: Oxford University Press, 2010.","DOI":"10.1093\/med\/9780199204854.003.070608_update_002"},{"key":"2025082701081465000_2016.oct26_1.bcr2016217223.2","doi-asserted-by":"crossref","first-page":"e14003","DOI":"10.7554\/eLife.14003","article-title":"A novel ciprofloxacin-resistant subclade of H58. Salmonella typhi is associated with fluoroquinolone treatment failure","volume":"5","author":"Pham Thanh","year":"2016","journal-title":"Elife"},{"key":"2025082701081465000_2016.oct26_1.bcr2016217223.3","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(15)00542-3"},{"key":"2025082701081465000_2016.oct26_1.bcr2016217223.4","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.3855\/jidc.4228","article-title":"Brief Original Article Re-emergence of susceptibility to conventional first line drugs in Salmonella isolates from enteric fever patients in Nepal","volume":"8","author":"Chand","year":"2014","journal-title":"J Infect Dev Ctries"},{"key":"2025082701081465000_2016.oct26_1.bcr2016217223.5","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(11)70089-5"},{"key":"2025082701081465000_2016.oct26_1.bcr2016217223.6","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(15)00530-7"},{"key":"2025082701081465000_2016.oct26_1.bcr2016217223.7","doi-asserted-by":"publisher","DOI":"10.1007\/BF01638944"},{"key":"2025082701081465000_2016.oct26_1.bcr2016217223.8","unstructured":"O'Neill J . Tackling Drug-Resistant Infections Globally: Final Report and Recommendations the Review on Antimicrobial Resistance . 2016."}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2016-217223","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T08:08:26Z","timestamp":1756282106000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2016-217223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,26]]},"references-count":8,"alternative-id":["10.1136\/bcr-2016-217223"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2016-217223","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2016,10,26]]}}}